Arcutis Biotherapeutics Inc (ARQT)
$32.07 +0.31% Close Oct 30, 2026 Live
Arcutis Biotherapeutics stock today
Arcutis Biotherapeutics closed at $32.07 on October 30, 2026, up 0.31% on the day. Over the past year it returned +28.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $4.01 billion.
$20.00$25.00$30.00
NovJan 2026MarMayJulSep
| Period | ARQT | S&P 500 (SPY) |
|---|---|---|
| 1 month | +21.3% | -0.9% |
| 3 months | +14.6% | +2.1% |
| Year to date | +10.4% | +11.7% |
| 1 year | +28.7% | +12.4% |
| 3 years | +1,294% | +88.5% |
| 5 years | +51.4% | +76.0% |
Key statistics
- Market value
- $4.01B
- P/E (trailing)
- 145.8
- Forward P/E
- 36.4
- Price / sales
- 8.6
- 52-week range
- $19.50 to $32.82
- Next report
- Nov 4, 2026
About Arcutis Biotherapeutics
Develops dermatology therapeutics for inflammatory skin diseases.
Sector: Health Care
More on Arcutis Biotherapeutics
- Financials: revenue, earnings and segmentsRevenue +91% in the year to Dec 2025
- Valuation: P/E history and peersP/E 145.8
- Returns: what $1,000 became$1,000 five years ago is $1,514 today
No forecast, no recommendation. This page describes Arcutis Biotherapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.